PRESS RELEASE published on 03/26/2025 at 23:00, 1 year 4 months ago Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile Onco-Innovations Limited announces successful nanoparticle formulation of PNKP Compound with low toxicity and effective cancer cell targeting in mice, promising safer treatment options Cancer Treatment Onco-Innovations Limited Nanoparticle Formulation PNKP Compound Low Toxicity
BRIEF published on 03/25/2025 at 22:05, 1 year 4 months ago Onco-Innovations Extends Marketing Partnership with MCS Digital Advertising Onco-Innovations Marketing Extension MCS Partnership CAD 600,000 Budget
BRIEF published on 03/25/2025 at 22:05, 1 year 4 months ago Onco-Innovations étend son partenariat marketing avec MCS Publicité Numérique Onco-Innovations Extension Marketing Partenariat MCS Budget De 600 000 $ CA
PRESS RELEASE published on 03/25/2025 at 22:00, 1 year 4 months ago Onco-Innovations Extends Marketing Program Onco-Innovations Limited extends engagement with MCS Market Communication Service GmbH for online marketing services until May 31, 2025. Company aims to revolutionize cancer treatment with patented technology Patented Technology Cancer Treatment Onco-Innovations Limited MCS Market Communication Service GmbH Online Marketing Services
BRIEF published on 03/24/2025 at 23:05, 1 year 4 months ago Onco-Innovations Updates Proceeds Utilization Strategy Investor Relations Equity Financing Research And Development Onco-Innovations Proceeds Update
BRIEF published on 03/24/2025 at 23:05, 1 year 4 months ago Onco-Innovations met à jour sa stratégie d'utilisation des bénéfices Recherche Et Développement Relations Avec Les Investisseurs Financement Par Actions Onco-Innovations Mise À Jour Des Recettes
PRESS RELEASE published on 03/24/2025 at 23:00, 1 year 4 months ago Onco-Innovations Provides Update on Use of Proceeds Onco-Innovations Limited provides an update on the use of proceeds from its Prospectus, focusing on investor relations activities and increased research and development spending for cancer treatments Investor Relations Research And Development Cancer Treatment Onco-Innovations Limited Use Of Proceeds
BRIEF published on 03/02/2025 at 21:05, 1 year 5 months ago Onco-Innovations CEO Discusses Breakthroughs in Cancer Treatment on Popular Program AI Integration Clinical Trials Cancer Treatment Precision Medicine Global Partnerships
BRIEF published on 03/02/2025 at 21:05, 1 year 5 months ago Le PDG d'Onco-Innovations évoque les avancées dans le traitement du cancer lors d'une émission populaire Essais Cliniques Traitement Du Cancer Intégration De L'IA Partenariats Mondiaux Médecine De Précision
PRESS RELEASE published on 03/02/2025 at 21:00, 1 year 5 months ago Onco-Innovations CEO Thomas O’Shaughnessy Featured on Conversations That Matter to Discuss Breakthroughs in Cancer Treatment, AI Integration, and Potential Global Expansion Onco-Innovations Limited's CEO, Thomas O'Shaughnessy, featured in an exclusive interview on Conversations That Matter discussing the Company's efforts in developing cancer treatment and strategic partnerships Clinical Trials Cancer Treatment Precision Medicine Onco-Innovations Limited Thomas O'Shaughnessy
Published on 08/07/2026 at 23:15, 1 day 7 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 1 day 8 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 1 day 8 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 1 day 8 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/09/2026 at 00:01, 7 hours 13 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 08/08/2026 at 16:25, 14 hours 49 minutes ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 1 day 7 hours ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 11 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day 11 hours ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:54, 1 day 12 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 1 day 12 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 12 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 1 day 12 hours ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 1 day 13 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026